0001214659-24-005796.txt : 20240401
0001214659-24-005796.hdr.sgml : 20240401
20240401163020
ACCESSION NUMBER: 0001214659-24-005796
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240328
FILED AS OF DATE: 20240401
DATE AS OF CHANGE: 20240401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AULT MILTON C III
CENTRAL INDEX KEY: 0001212502
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40483
FILM NUMBER: 24809826
MAIL ADDRESS:
STREET 1: 11411 SOUTHERN HIGHLANDS PARKWAY
STREET 2: SUITE 240
CITY: LAS VEGAS
STATE: NV
ZIP: 89141
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alzamend Neuro, Inc.
CENTRAL INDEX KEY: 0001677077
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 811822909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 3500 LENOX RD. NE
STREET 2: SUITE 1500
CITY: ATLANTA
STATE: GA
ZIP: 30326
BUSINESS PHONE: 844-722-6333
MAIL ADDRESS:
STREET 1: 3500 LENOX RD. NE
STREET 2: SUITE 1500
CITY: ATLANTA
STATE: GA
ZIP: 30326
4
1
marketforms-65425.xml
PRIMARY DOCUMENT
X0508
4
2024-03-28
0001677077
Alzamend Neuro, Inc.
ALZN
0001212502
AULT MILTON C III
11411 SOUTHERN HIGHLANDS PARKWAY
SUITE 240
LAS VEGAS
NV
89141
true
false
true
false
0
Common Stock
2024-01-05
4
P
false
2000
1.0635
A
770365
I
By Ault Lending, LLC
Common Stock
166865
D
Common Stock
996197
I
By Ault Life Sciences, Inc.
Common Stock
5498
I
By Ault Life Sciences Fund, LLC
Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.
/s/ Milton C. Ault, III
2024-04-01